Alexander Lee is currently employed as an Associate in HEOR & Access at FIECON since September 2023. Previously, Alexander interned at PwC during the Digital Insight Week in July 2019, where insights into emerging technologies and teamwork were gained. Additionally, Alexander served as a Venture Capital Intern at Praetura Ventures in June 2019, engaging in various business meetings and evaluating startup pitch decks. Alexander holds a Bachelor’s degree in Economics from UCL, completed in 2023, and attended The Manchester Grammar School from 2011 to 2020.
Upgrade to view 0 reports
This person is not in any offices
FIECON
FIECON was born out of the desire to make a difference in the world we live in – harnessing the power of health economics for the good of humanity. To date, we have donated over £900,000 to charitable causes. Our services: We provide services across the life cycle of a product and have worked in countries across the globe. Our key service areas comprise: • Outcomes Research • Economic Modelling • Health Technology Assessment • Value Communication • Pricing & Reimbursement Our products: We challenge the conventional and think outside the box to provide game-changing, innovative products that meet your commercial needs. Our products include: • FIECON Model Builder • FIECON Value Platform • FIECON Modelling Center powered by FIECON Model Builder Our vision is to use economics for the good of humanity. We do this by making a positive difference in the lives of our people, our clients, and our society. Our core values guide our day-to-day actions and make FIECON a great place to work: * Learn, Grow, and Flourish Together * Deliver Results and Delight Clients * Improve Lives and Build a Better World Our ultimate aspiration is to set the bar for how workplaces operate, and by 2030 we aim to achieve a number of goals: We want to test the hypothesis that you can maintain a great culture as you grow, achieving external certification through the Great Place to Work award. We want to show that we have affected millions of lives – 100M in fact – which we can quantify based on the drugs we take to market each year. We want to give back BIG both in terms of our time and donations – £10M since our founding is the first stake in the ground. We also want to demonstrate that we are meeting the highest standards for social responsibility by achieving B-Corp status. hello@fiecon.com
Industries
Employees
51-200